Comparison

Recombinant Human IGFBP-3 Protein (His Tag) European Partner

Item no. 10430-H07H-1
Manufacturer Sino Biological
Amount 1 mg
Quantity options 1 mg 100 ug 2 mg 20 ug 4 mg 5 ug 500 ug
Category
Type Proteins
Specific against Human (Homo sapiens)
Conjugate/Tag HIS
Purity > 85 % as determined by SDS-PAGE
Sequence Gly28-Lys291
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias BP-53,IBP3
Similar products IGFBP3
Available
Manufacturer - Type
Protein
Manufacturer - Conjugate / Tag
N-His
Shipping Temperature
In general, recombinant proteins are provided as lyophilized powder which are shipped at ambient temperature.
Bulk packages of recombinant proteins are provided as frozen liquid. They are shipped out with blue ice unless customers require otherwise.
Storage Conditions
Store it under sterile conditions at -20C to -80C. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Antigen molecule name
IGFBP3
Protein Construction
A DNA sequence encoding the mature form of human IGFBP3 (NP_000589.2) (Gly28-Lys 291) was fused with a polyhistidine tag at the N-terminus.
Expressed Host
Human Cells
Bio-Activity
1. Measured by its binding ability in a functional ELISA. Immobilized human IGF2 (Cat:13032-H24E) at 10 ug/mL (100 ul/well) can bind biotinylated Human His-IGFBP3, The EC50 of biotinylated Human His-IGFBP3 is 18 ng/mL.
2. Measured by its binding ability in a functional ELISA. Immobilized human IGF1 (Cat:10598-H24E) at 10 ug/mL (100 ul/well) can bind biotinylated Human His-IGFBP3, The EC50 of biotinylated Human His-IGFBP3 is 24 ng/mL.
3. Measured by its ability to inhibit the biological activity of IGFI or IGFII on MCF7 human breast adenocarcinoma cells (Karey, K.P. et al. (1988) Cancer Research 48:4083.). The ED50 for this effect is typically 0.02-0.2 ug/mL in the presence of 14 ng/mL human IGFII.
Endotoxin
< 1.0 EU per ug of the protein as determined by the LAL method
Predicted N Terminal
His 1
Molecule Mass
The secreted recombinant human IGFBP3 comprises 280 amino acids with a predicted molecular mass of 31 kDa. As a result of glycosylation, the apparent molecular mass of rhIGFBP3 is approximately 40-45 kDa in SDS-PAGE under reducing conditions.
Formulation
Lyophilized from sterile PBS, pH 7.4

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close